Results 141 to 150 of about 8,916 (246)

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: Application of a novel pharmacodynamic assay [PDF]

, 2016
et al,, Vij, Ravi
core   +2 more sources

Supplementary Table 2 from The <i>LMP7-K</i> Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer

, 2023
Barbara Fellerhoff, Songhai Gu, Barbara Laumbacher, Andreas G. Nerlich, Elisabeth H. Weiss, Jürgen Glas, Reinhard Kopp, Judith P. Johnson, Rudolf Wank   +8 more
openalex   +1 more source

Argyrin B, a non‐competitive inhibitor of the human immunoproteasome exhibiting preference for β1i [PDF]

, 2019
Duncan Allardyce, Celia Bell, Eriketi Z. Loizidou   +2 more
openalex   +1 more source

Papel del inmunoproteosoma en enfermedades neurodegenerativas y cáncer [PDF]

, 2016
Los avances científicos y la constante evolución de los métodos de experimentación han permitido conocer la gran importancia que tiene el proteosoma en nuestro organismo.
Laffitte Redondo, Clara
core  

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma [PDF]

, 2022
Raul Maia Falcão, Georgia Kokaraki, Wout De Wispelaere, Frédéric Amant, Gustavo A. de Souza, Jorge Estefano Santana de Souza, Joseph W. Carlson, Tirzah Braz Petta Lajus   +7 more
openalex   +1 more source

Effects of ErbB2 overexpression on the proteome and ErbB ligand-specific phosphosignalling in mammary luminal epithelial cells [PDF]

, 2017
Most breast cancers arise from luminal epithelial cells and 25-30% of these tumours overexpress the ErbB2/HER2 receptor which correlates with disease progression and poor prognosis. The mechanisms of ErbB2 signalling and the effects of its overexpression
Spain, G, Timms, JF, Worthington, J
core  

Role of Immunoproteasome Catalytic Subunits in the Immune Response to Hepatitis B Virus

, 2006
Michael D. Robek, Mayra L. Garcia, Bryan Boyd, Francis V. Chisari   +3 more
openalex   +2 more sources

AB0509 Kzr-616, a selective inhibitor of the immunoproteasome, shows a promising safety and target inhibition profile in a phase i, double-blind, single (SAD) and multiple ascending dose (MAD) study in healthy volunteers [PDF]

, 2018
Jason D. Lickliter, D. Bomba, Janet L. Anderl, Agnes Fan, Christopher J. Kirk, J. Wang   +5 more
openalex   +1 more source

Age‐related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects [PDF]

, 2008
María P. Gavilán, Angélica Castaño, M. Torres, Manuel Portavella, Cristina Caballero, Sebastián Jiménez, Ana García‐Martínez, Juan Parrado, Javier Vitórica, Diego Ruano   +9 more
openalex   +1 more source

Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers [PDF]

, 2023
Karen Geoffroy, Bruna Araripe Saraiva, Mélissa Viens, Delphine Béland, Marie‐Claude Bourgeois‐Daigneault   +4 more
openalex   +1 more source